Welcome to our dedicated page for Claritev SEC filings (Ticker: CTEV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Claritev Corporation (NYSE: CTEV) files a range of documents with the U.S. Securities and Exchange Commission that detail its operations as a healthcare technology, data and insights company. As an issuer of Class A common stock listed on the New York Stock Exchange, Claritev provides investors with periodic and current reports that describe its financial performance, capital structure, client relationships and key corporate events.
On this page, you can access Claritev’s SEC filings, including current reports on Form 8-K that the company uses to announce material developments. Recent 8-K filings have covered topics such as quarterly financial results, contract renewals with its ten largest clients, underwriting agreements for secondary offerings of Class A common stock by selling stockholders, and changes in executive roles. These filings also confirm that Claritev’s Class A common stock, with a par value of $0.0001 per share, is registered under Section 12(b) and trades under the symbol CTEV on the NYSE.
Claritev’s earnings-related filings and exhibits provide detail on revenues, net income or loss, and non-GAAP metrics such as EBITDA, Adjusted EBITDA, Free Cash Flow, Unlevered Free Cash Flow and an Adjusted cash conversion ratio. The company defines these measures and explains their limitations, giving investors insight into how management evaluates performance and cash generation alongside GAAP results.
Through Stock Titan, these filings are complemented by AI-powered summaries that help explain the significance of each document. Investors can quickly see the key points from Claritev’s 8-Ks, and, where available, review annual reports on Form 10-K, quarterly reports on Form 10-Q, proxy materials and other disclosures. This page also provides a pathway to monitor any insider-related filings, such as Form 4 reports, that may be associated with Claritev’s equity compensation and ownership changes, offering a structured view of the company’s regulatory reporting history.
Claritev Corporation reported Q4 2025 revenue of $246.6 million, up 6.2% from Q4 2024, and narrowed its quarterly net loss to $80.6 million. Adjusted EBITDA for Q4 was $151.3 million with a 61.4% margin, and free cash flow improved to $36.4 million.
For full-year 2025, revenue reached $965.4 million, a 3.7% increase, while the net loss shrank sharply to $284.3 million from $1.65 billion. Full-year Adjusted EBITDA rose to $602.6 million, and operating cash flow was $117.3 million.
The company issued 2026 guidance with revenue between $980 million and $1 billion, Adjusted EBITDA of $605 million to $615 million, capital expenditures of $160 million to $170 million, and free cash flow between $0 million and $10 million. The board also approved a five-year share repurchase program authorizing up to $75 million of Class A common stock, capped at $20 million per year and funded from cash on hand and operations.
Claritev Corp reported that SVP and Chief People Officer Carol Nutter acquired 1,884 shares of Class A common stock through an earned performance-based restricted stock unit (PSU) award. This increased her direct holdings to 30,748 shares.
The PSUs were earned after the Compensation Committee certified that Claritev’s revenue for the two-year performance period ending December 31, 2025 met revenue-based performance criteria. The company’s total revenue versus target resulted in Nutter earning 67% of the originally awarded PSUs. These earned PSUs are scheduled to vest in the first quarter of 2027, subject to her continued employment with Claritev under the 2020 Omnibus Incentive Plan and the applicable PSU award agreement.
Claritev Corp executive vice president and chief digital officer Kim Michael reported an acquisition of 2,444 shares of Class A common stock at $0.0000 per share through a grant/award transaction. These represent earned performance-based restricted stock units tied to the company’s revenue.
The units were earned at 67% of the original performance award after the compensation committee certified revenue-based results for the two-year period ending December 31, 2025. The PSUs are scheduled to vest in the first quarter of 2027, subject to continued employment. Following this award, Michael directly holds 107,973 shares.
Claritev Corp reported that SVP and General Counsel Tara O'Neil acquired 1,421 shares of Class A common stock through an earned grant, not an open-market purchase. The award consists of performance-based restricted stock units that were earned after revenue criteria were met for a two-year period ending December 31, 2025.
These performance stock units are scheduled to vest in the first quarter of 2027, subject to her continued employment with Claritev under the company’s 2020 Omnibus Incentive Plan. Following this award, her directly held Class A common stock totaled 26,449 shares.
Claritev Corp executive vice president and chief operating officer Jerome Hogge reported an equity compensation grant. He acquired 8,723 shares of Class A common stock at a price of $0.00 per share as a grant or award, bringing his direct holdings to 98,746 shares.
The award represents earned performance-based restricted stock units that will vest in the first quarter of 2027, subject to his continued employment. These PSUs were tied to a two-year revenue performance period ending December 31, 2025, with company revenue levels resulting in him earning 67% of the originally awarded units.
Claritev Corp’s latest Schedule 13G/A shows that investment firm Arini Capital Management Limited and related entities report beneficial ownership of 1,503,892 shares of Claritev common stock, representing 9.11% of the class based on 16,509,496 Class A ordinary shares.
Arini and affiliates report shared voting and dispositive power over these shares, with no sole voting or dispositive power. Within this group, Arini Credit Master Fund Limited holds 1,428,697 shares (8.65%), and Squarepoint Diversified Partners Fund 7 Limited holds 75,195 shares (0.46%). The filing states the securities are not held for the purpose of changing or influencing control of Claritev. Founder and CIO Hamza M. Lemssouguer, as sole owner of Arini Capital Management Holdings (Jersey) Limited, may be deemed a beneficial owner of the reported shares.
Claritev Corp executive Brock Albinson reported an equity award. On December 31, 2025, the SVP and Chief Accounting Officer received 1,169 shares of Class A common stock at $0 per share, reported as a grant of restricted stock units.
The restricted stock units vest in four equal installments of 25% each on December 31, 2026, 2027, 2028 and 2029. Following this grant, Albinson directly beneficially owns 3,994 Class A common shares.
Claritev Corporation furnished an investor slide presentation through a current report. Beginning on January 15, 2026, the company is making this presentation available on its website for investors, and it is also attached as Exhibit 99.1 to the report. The material is provided under Regulation FD, which is intended to ensure that all investors have equal access to important company information.
The company states that the presentation and related disclosure are being "furnished" rather than "filed," meaning they are not subject to certain liability provisions of the securities laws and are not automatically incorporated into other SEC filings unless specifically referenced.
Claritev Corporation reported that Dale White, its former Chief Executive Officer and Executive Chair and currently a director, will end his role as a strategic advisor to the company effective December 31, 2025. He has served in this advisory capacity since stepping down as Executive Chair on December 31, 2024. The company waived its contractual right to 30 days' written notice for ending the advisory role, and no additional compensation is due to Mr. White for this service. Mr. White will continue to serve on Claritev's board of directors.
Claritev Corp (CTEV) president, CEO, executive chair and director reported a personal-related purchase of Class A common stock. On 11/20/2025, the reporting person acquired 5,290 shares at a weighted average price of $47.2291 per share through the spouse's individual retirement account, which is reported as indirect ownership. After this transaction, indirect holdings in that account totaled 9,572 Class A shares, while direct ownership was reported as 243,058 Class A shares. The price range for the purchases on that date was from $47.0000 to $47.2300 per share.